PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34471776-2	2021	Such agents would improve our understanding of the nitric oxide (NO)/cyclic guanosine 3",5"-monophosphate (cGMP)/PDE5 pathway in human pathologies and potentially lead to novel uses of PDE5 inhibitors to manage lung conditions like SARS-CoV-2-mediated pulmonary inflammatory responses.	Cyclic GMP	69-105	phosphodiesterase 5A	Homo sapiens	113-117	
34471776-2	2021	Such agents would improve our understanding of the nitric oxide (NO)/cyclic guanosine 3",5"-monophosphate (cGMP)/PDE5 pathway in human pathologies and potentially lead to novel uses of PDE5 inhibitors to manage lung conditions like SARS-CoV-2-mediated pulmonary inflammatory responses.	Cyclic GMP	69-105	phosphodiesterase 5A	Homo sapiens	185-189	
34471776-2	2021	Such agents would improve our understanding of the nitric oxide (NO)/cyclic guanosine 3",5"-monophosphate (cGMP)/PDE5 pathway in human pathologies and potentially lead to novel uses of PDE5 inhibitors to manage lung conditions like SARS-CoV-2-mediated pulmonary inflammatory responses.	Cyclic GMP	107-111	phosphodiesterase 5A	Homo sapiens	113-117